NCT02700529View on ClinicalTrials.gov

Ubenimex in Adult Patients With Lymphedema of The Lower Limb (ULTRA)

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

October 31, 2018

Study Completion Date

February 28, 2019

Conditions
Lymphedema
Interventions
DRUG

ubenimex

OTHER

placebo

Trial Locations (4)

2109

Macquarie University Hospital (MUH), Sydney

32806

Orlando Health, Inc., Orlando

43210

The Ohio State University Wexner Medical Center James Cancer Hospital, Columbus

94305

Stanford University, Stanford

Sponsors
All Listed Sponsors
lead

Eiger BioPharmaceuticals

INDUSTRY

NCT02700529 - Ubenimex in Adult Patients With Lymphedema of The Lower Limb (ULTRA) | Biotech Hunter | Biotech Hunter